| ¿µ¹® | defense mechanism | ÇÑ±Û | ¹æ¾î¸ÞÄ¿´ÏÁò |
|---|---|---|---|
| ¼³¸í | 1.»ýü°¡ ¿ÜºÎÀڱؿ¡ ´ëÇÏ¿© Àڽſ¡°Ô ÀÌ·Ó°Ô µÇ±â À§ÇÑ ÀÏ·ÃÀÇ ±âÀüÀ» ÅëĪÇÏ´Â ¸». 2.ÇÁ·ÎÀÌÆ®°¡ ¹àÈù Á¤½ÅºÐ¼®ÀÇ Áß½ÉÀû ÀÌ·Ð °³³äÀÇ Çϳª, °¨Á¤Àû °¥µîÀ» ÇØ¼ÒÇϰí, °³ÀÎÀ» ºÒ¾È¿¡¼ ÇØ¹æ½Ã۱â À§ÇÑ ¹«ÀǽÄÀû Á¤½ÅÀÛ¿ë °úÁ¤ÀÌ´Ù. ¹æ¾î±âÀü¿¡´Â ¾ï¾Ð, µµÇÇ, ¹æ¾îÀû °ø°Ý, ¹Ýµ¿Çü¼º, Åõ»ç, ÀüÀ§, ½ÂÈ, ÅõÀÔ, ÀÚÃ¥, ÅðÇà, °Ý¸®, ´ë¸®Çü¼º, »óȯ, Àüȯ, ÇØ¸®, ´ë»ó, ºÎÁ¤ µîÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | host | ÇÑ±Û | ¼÷ÁÖ |
|---|---|---|---|
| ¼³¸í | ´Ù¸¥ »ý¹°(±â»ýü)À» ±â»ý½ÃÄÑ, ¿µ¾çÀ» °ø±ÞÇÏ´Â µ¿¹° ¶Ç´Â ½Ä¹°. ¸¶Áö¸·ÀÇ ¼öÁÖ¸¦ Á¾¼÷ÁÖ, ¹ßÀ°ÀÇ µµÁß¿¡ ±â»ýÇÏ´Â ¼÷ÁÖ¸¦ Áß°£ ¼÷ÁÖ¶ó°í ÇÑ´Ù. ±â»ýµ¿¹° Áß¿¡´Â ¼÷ÁÖ°¡ ƯÁ¤ÇÑ Á¾ÀÏ ¶§µµ ÀÖ°í ¶Ç ¸¹Àº ±â»ýÃæ°ú °°ÀÌ±× ¹ß»ý´Ü°è¿¡ µû¶ó ¸¹Àº Á¾·ùÀÇ ¼÷ÁÖ¸¦ ÇÊ¿ä·Î ÇÏ´Â °Íµµ ÀÖ´Ù. ÀÌ °æ¿ì ¾Ö¹ú·¹°¡ ±â»ýÇÏ´Â ¼÷ÁÖ¸¦ Áß°£¼÷ÁÖ, ¼ºÃ¼°¡ ±â»ýÇÏ´Â ¼÷ÁÖ¸¦ ÃÖÁ¾¼÷ÁÖ¶ó°í ÇÑ´Ù. °£ÁúÀÎ °æ¿ì¿¡´Â ¹°°íµ¿ÀÌ Áß°£¼÷ÁÖÀ̰í, ¼Ò-¾ç µîÀº ÃÖÁ¾¼÷ÁÖ°¡ µÈ´Ù. ±â»ý½Ä¹°¿¡´Â °Ü¿ì»ìÀÌ¿Í °°ÀÌ Á¹Âü³ª¹« µîÀ» ¼÷ÁÖ·Î ÇÏ¿© ½º½º·Î ±¤ÇÕ¼ºÀ» Çϸ鼵µ ¼÷ÁÖ¿¡°Ô¼ ¿µ¾çÀ» ¾ò´Â °Í°ú, ¾ß°í¿Í °°ÀÌ »ý° µîÀÇ »Ñ¸®¸¦ ¼÷ÁÖ·Î ÇÏ¿© ¼÷ÁÖ¿¡°Ô¼¸¸ ¿µ¾çÀ» ÀÇÁ¸ÇÏ´Â °ÍÀÌ ÀÖ´Ù. ±â»ý»ý¹°¿¡´Â ÀÌ ¹Û¿¡µµ »ý¹°ÀÇ »çü³ª ±× ºÐÇØÁß¿¡ ÀÖ´Â °Í, ¹èÃâ¹° µîÀ» ¼÷ÁÖ·Î ÇÏ´Â °Íµµ ÀÖ´Ù. |
||
| ¿µ¹® | graft versus host reaction | ÇÑ±Û | ÀÌ½ÄÆí´ë ¼÷ÁÖ¹ÝÀÀ |
|---|---|---|---|
| ¼³¸í | ¸é¿ªÀ̶õ ÀÚ½ÅÀÇ °Í°ú ÀÚ½ÅÀÇ °ÍÀÌ ¾Æ´Ñ °ÍÀ» ±¸ºÐÇØ¼ ÀÚ½ÅÀÇ °ÍÀÌ ¾Æ´Ñ °ÍÀ» °ø°ÝÇÏ¿© »ý¹°ÇÐÀû Ȱ¼ºÀ» ¾ø¾Ö°Å³ª Á¦°ÅÇÏ´Â °ÍÀÌ´Ù. ÀÌ ¸é¿ªÀº ÁÖ·Î Ç÷¾×¿¡ ÀÖ´Â ¼¼Æ÷¿¡ ÀÇÇØ¼ ÀÌ·ç¾îÁø´Ù. ƯÈ÷ ¸²ÇÁ±¸´Â ÀÌ ¸é¿ª¿¡ ÁßÃßÀûÀÎ ¿ªÇÒÀ» ÇÏ´Â ¼¼Æ÷ÀÌ´Ù. ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀÀ̶ó´Â °ÍÀº À̽ĵǾî¿Â Á¶Á÷¿¡ Á¸ÀçÇϴ ŸÀÎÀÇ Ç÷±¸µéÀÌ ¼÷ÁÖÀÇ ¼¼Æ÷¸¦ °ø°ÝÇÏ´Â °ÍÀ» ¸»ÇÑ´Ù. Áï À̽ĵǾî¿Â Á¶Á÷°ú ÇÔ²² µé¾î¿Â Ç÷±¸µéÀÌ À̽ÄÀ» ¹ÞÀº »ç¶÷ÀÇ ¼¼Æ÷¸¦ ŸÀÎÀÇ °ÍÀ¸·Î ÀÎÁöÇØ¼ °ø°ÝÇÏ´Â Çö»óÀÌ´Ù. À̰ÍÀº À̽ÄÀ» ¹ÞÀº »ç¶÷ÀÇ ¸é¿ª»óŰ¡ Á¤»óÀûÀÏ °æ¿ì¿¡´Â ÀϾÁö ¾Ê´Âµ¥ ¿Ö³ÄÇÏ¸é ¸é¿ª»óŰ¡ Á¤»óÀÏ °æ¿ì¿¡´Â À̽ĵǾî¿Â Àå±â¿Í ´õºÒ¾î µé¾î¿Â ŸÀÎÀÇ Ç÷±¸µéÀ» À̽ÄÀ» ¹ÞÀº »ç¶÷ÀÇ Ç÷±¸°¡ ŸÀÎÀÇ °ÍÀ¸·Î ÀÎÁöÇØ¼ °ø°ÝÀ» ÇÏ°í ¼ýÀûÀ¸·Î À¯¸®ÇÏ¿© ¸ðµÎ Á×ÀÏ ¼ö°¡ Àֱ⠶§¹®ÀÌ´Ù. |
||
| HDF | host defense factor; human diploid fibroblast |
|---|---|
| DMI | Defense Mechanism Inventory; Diagnostic Medical Instruments; diaphragmatic myocardial infarction; di... |
| E-D | ego-defense; Ehlers-Danlos [syndrome] |
| ICNND | Interdepartmental Committee on Nutrition in National Defense |
| IDM | idiopathic disease of myocardium; immune defense mechanism; indirect method; infant of diabetic moth... |
| DMI | Defense Mechanism Inventory |
|---|---|
| DOD | Department of Defense |
| IDF | Israel Defense Force |
| AGVHD | Acute graft-versus-host disease |
| aGVHD | Acute graft-vs.-host disease |
| perceptual defense | Selective perceiving such that the individual protects himself from becoming aware of something unpleasant or threatening, e.g., obscene words are not heard correctly, or violent acts are not seen accurately. (12 Dec 1998) |
|---|---|
| civil defense | Preventive emergency measures and programs designed to protect the individual or community in times of hostile attack. (12 Dec 1998) |
| screen defense | The use of falsified or incomplete memories or affects to cover repressed but associated memories and affects. (05 Mar 2000) |
| defense | The psychological mechanisms used to control anxiety, e.g., rationalization, projection. Origin: L. Defendo, to ward off (05 Mar 2000) |
| defense mechanism | A psychological means of coping with conflict or anxiety, e.g., conversion, denial, dissociation, rationalization, repression, sublimation, the psychic structure underlying a coping strategy, immunological mechanism vs. Non-specific defense mechanism. (05 Mar 2000) |
| defense mechanisms | Unconscious process used by an individual or a group of individuals in order to cope with impulses, feelings or ideas which are not acceptable at their conscious level; various types include reaction formation, projection and self reversal. (12 Dec 1998) |
| defense reflex | Automatic reactions of an animal, e.g., raising of hair or feathers, dilation of the pupils, or baring of claws, when alarmed. (05 Mar 2000) |
| insanity defense | A legal concept that a person cannot be convicted of a crime if he lacked criminal responsibility by reason of insanity, which term is defined as a matter of law. (12 Dec 1998) |
| accidental host | One that harbors an organism which usually does not infect it. (05 Mar 2000) |
| amplifier host | A host in which infectious agents multiply rapidly to high levels, providing an important source of infection for vectors in vector-borne diseases. (05 Mar 2000) |
| parasite-host ecosystem | Complex of all parasite species and individuals associated with a specific host. Synonym: parasite-host ecosystem. Origin: parasite + G. Koinos, common, together (05 Mar 2000) |
| paratenic host | An intermediate host in which no development of the parasite occurs, although its presence may be required as an essential link in the completion of the parasite's life cycle; e.g., the successive fish host's that carry the plerocercoid of Diphyllobothrium latum, the broad fish tapeworm, to larger food fish eventually eaten by man or other final host's. Synonym: transport host. (05 Mar 2000) |
| reservoir host | The host of an infection in which the infectious agent multiplies and/or develops, and upon which the agent is dependent for survival in nature; the host essential for the maintenance of the infection during times when active transmission is not occurring. (05 Mar 2000) |
| graft-versus-host disease | <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue. When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage. The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign. The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin. Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel. Synonym: GVH disease. Acronym: GVHD (20 Sep 2002) |
| graft-versus-host reaction | <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue. When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage. The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign. The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin. Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel. Synonym: GVH disease. Acronym: GVHD (20 Sep 2002) |
| host defense mechanisms |
A complex interacting system that protects the host from endogenous and exogenous microorganisms. It includes physical and chemical barriers, inflammatory response, reticuloendothelial system, and immune responses. SEE:
Ãâó:
|
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|